High HIV sexual risk behaviors and sexually transmitted disease prevalence among injection drug users in Northern Vietnam: Implications for a generalized HIV epidemic

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 1, 2006, Pages 108-115

  Go, Vivian F ^a   Frangakis, Constantine ^a,b   Van Nam, Le ^c   Bergenstrom, Anna ^a   Sripaipan, Teerada ^a   Zenilman, Jonathan M ^d   Celentano, David D ^a   Minh Quan, Vu ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

^c Bac Ninh Department of Public Health   (Viet Nam)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; Injection drug users; Risk factors; Sexually transmitted diseases; Vietnam

Indexed keywords

DIAMORPHINE;

ADULT; ARTICLE; CHLAMYDIASIS; DISEASE ASSOCIATION; EPIDEMIC; FEMALE; GONORRHEA; HEROIN DEPENDENCE; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; QUALITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; UNEMPLOYMENT; VIET NAM;

CHLAMYDIA INFECTIONS; CROSS-SECTIONAL STUDIES; FEMALE; GONORRHEA; HEROIN; HERPES SIMPLEX; HUMANS; INTERVIEWS; MALE; PREVALENCE; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SMOKING; SUBSTANCE ABUSE, INTRAVENOUS; SYPHILIS; UNEMPLOYMENT; URBAN POPULATION; VIETNAM;

EID: 33745441071     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000199354.88607.2f     Document Type: Article

References (46)

1. Des Jarlais DC, Friedman SR, Hopkins W. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann Intern Med. 1985;103:755-759.
2. Chaisson RE, Moss AR, Onishi R, et al. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health. 1987;77:169-172.
3. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874-879.
4. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
5. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281-1288.
6. Strathdee SA. Sexual HIV transmission in the context of injection drug use: implications for interventions. Int J Drug Policy. 2003;14:79-81.
7. Saidel TJ, Des Jarlais D, Peerapatanapokin W, et al. Potential impact of HIV among IDUs on heterosexual transmission in Asian settings: scenarios from the Asian Epidemic Model. Int J Drug Policy. 2003;14:63-74.
8. Wiessing L, Kretzschmar M. Can HIV epidemics among IDUs 'trigger' a generalised epidemic? Int J Drug Policy. 2003;14:99-102.
9. Lowndes CM, Renton A, Alary M, et al. Conditions for widespread heterosexual spread of HIV in the Russian Federation: implications for research, monitoring and prevention. Int J Drug Policy. 2003;14:45-62.
10. Quan VM, Chung A, Long HT, et al. HIV in Vietnam: the evolving epidemic and the prevention response, 1996 through 1999. J Acquir Immune Defic Syndr. 2000;25:360-369.
11. United Nations Office on Drugs and Crime. Country profile on Vietnam. United Nations Office on Drugs and Crime, Hanoi, October 30, 2004. Available at: http://www.unodc.org/pdf/vietnam/country_profile_ vietnam.pdf.
12. Vietnam National Drug Control Program. Vietnam Drug Control Masterplan. Hanoi: Vietnam Drug Control Program; 1995.
13. General Department of HIV/AIDS Prevention and Control. Annual Report on HIV Program in Vietnam, 2004. Hanoi: Ministry of Health; 2004.
14. UNAIDS. 2004 Report on the Global AIDS Epidemic. Geneva: UNAIDS; 2004.
15. Tung ND, Tuan NA, Hoang TV, et al. HIV/AIDS Behavioral Surveillance Survey, Vietnam 2000. Hanoi: National AIDS Standing Bureau, Family Health International; 2001.
16. Hien NT, Giang LT, Binh PN, et al. The social context of HIV risk behaviour by drug injectors in Ho Chi Minh City, Vietnam. AIDS Care. 2000;12:483-495.
17. Nguyen TA, Hoang LT, Pham VQ, et al. Risk factors for HIV-1 seropositivity in drug users under 30 years old in Haiphong, Vietnam. Addiction. 2001;96:405-413.
18. Phan TL, Elias C, Nguyen TL, et al. The prevalence of reproductive tract infections in Hue, Vietnam. Stud Fam Plann. 2002;33:217-226.
19. Nguyen TH, Nguyen TL, Trinh QH. HIV/AIDS epidemics in Vietnam: evolution and responses. AIDS Educ Prev. 2004;16:137-154.
20. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19:61-77.
21. Laga M. Interactions between STDs and HIV infection. STD Bull. 1992;13:3-6.
22. Quan VM, Go VF, Bergenstrom A, et al. HIV prevalence and associated risks among injection drug users in northern Vietnam. Presented at: XV International AIDS Conference; 2004; Bangkok.
23. Nguyen AT, Nguyen TH, Pham KC, et al. Intravenous drug use among street-based sex workers: a high-risk behavior for HIV transmission. Sex Transm Dis. 2004;31:15-19.
24. Hien NT, Giang LT, Binh PN, et al. Risk factors of HIV infection and needle sharing among injecting drug users in Ho Chi Minh City, Vietnam. J Subst Abuse. 2001;13:45-58.
25. Quan VM, Chung A, Abdul-Quader AS. The feasibility of a syringe-needle-exchange program in Vietnam. Subst Use Misuse. 1998;33: 1055-1067.
26. SAS Institute. I. SAS Institute, version 9.1 [computer program]. Cary, NC: SAS Institute; 2004.
27. Muhr T. Atlas TI, version 4.1 [computer program]. Berlin: Scientific Software Development; 1997.
28. Nguyen AT, Nguyen TH, Pham KC, et al. Intravenous drug use among street-based sex workers: a high-risk behavior for HIV transmission. Sex Transm Dis. 2004;31:15-19.
29. Tran TN, Detels R, Long HT, et al. Drug use among female sex workers in Hanoi, Vietnam. Addiction. 2005;100:619-625.
30. Bachmann LH, Lewis I, Allen R, et al. Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility. Am J Public Health. 2000;90:1615-1618.
31. Hwang LY, Ross MW, Zack C, et al. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis. 2000;31:920-926.
32. Latka M, Ahern J, Garfein RS, et al. Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. J Subst Abuse. 2001;13:73-88.
33. Beyrer C, Razak MH, Jittiwutikarn J, et al. Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking substance abusers. Int J STD AIDS. 2004;15:697-704.
34. Friedman SR, Flom PL, Kottiri BJ, et al. Drug use patterns and infection with sexually transmissible agents among young adults in a high-risk neighbourhood in New York City. Addiction. 2003;98:159-169.
35. Gotz HM, van Bergen JE, Veldhuijzen IK, et al. A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect. 2005;81:24-30.
36. Fenton KA, Mercer CH, Johnson AM, et al. Reported sexually transmitted disease clinic attendance and sexually transmitted infections in Britain: prevalence, risk factors, and proportionate population burden. J Infect Dis. 2005;191(Suppl 1):S127-S138.
37. McCormack WM, Alpert S, McComb DE, et al. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med. 1979;300:123-125.
38. Molano M, Meijer CJ, Weiderpass E, et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis. 2005;191:907-916.
39. Wieland WF, Yunger M. Sexual effects and side effects of heroin and methadone. In: Proceedings of the Third National Conference on Methadone Treatment. Washington, DC: MMH; 1970:50-53.
40. Mirin SM, Meyer RE, Mendelson JH, et al. Opiate use and sexual function. Am J Psychiatry. 1980;137:909-915.
41. Beschner GM, Bouvelle EI. Life with heroin: voices of experience. In: Hanson B, Beschner G, Walters JM, Bouvelle E, eds. Life with Heroin: Voices from the Inner City. Toronto: Lexington Books; 1985: 75-107.
42. Griffiths P, Gossop M, Powis B, et al. Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues. Addiction. 1993;88:1617-1626.
43. Powis B, Strang J, Griffiths P, et al. Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction. 1999;94:471-478.
44. Reiss I, Leik R. Evaluating strategies to avoid AIDS: number of partners vs. use of condom. J Sex Res. 1989;26:411-433.
45. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185:45-52.
46. Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach intervention. Health Psychol. 2003;22:332-339.